Skip to content
Insider tapeLive · 5:07 PM ET
My stocks

Amit Sachdev

At a glance: Amit Sachdev is Evp Chief Patient & Ext Af Off at Vertex Pharmaceuticals (VRTX). Their latest SEC Form 4, filed Feb 26, 2026, reported a sale of $898K. On file: 0 purchase lines ($0) and 9 sale lines ($28.4M).

Disclosed holdings: about $29.0M of VRTX stock: 55,570 shares reported on their latest Form 4 (filed Feb 26, 2026), valued at the Nov 19, 2026 close of $521.30. This counts only VRTX shares reported to the SEC; it leaves out cash, other investments, options and unvested awards, so it is not total net worth.

Evp Chief Patient & Ext Af Off at Vertex Pharmaceuticals Inc / Ma (VRTX)

Purchase track record

Not enough history. Based on 0 purchases with a full 90 days of price history.

—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $28.4M

Amit Sachdev's InsiderPrint

9 trades from SEC Form 4 filings, 2026 to 2026, drawn as one fingerprint.

InsiderPrint of Amit Sachdev: 9 trades, 2026 to 20262026: 0 buys, 9 sales

Reading this print: Almost only sells, trading about 9 times a year, typically $2.0M a trade; most sales are on a pre-planned 10b5-1 schedule; trades in the same month most years.

  • Bump outward: a purchase (0)
  • Dent inward: a sale (9)
  • One ring per year, oldest in the middle, Jan at the top going clockwise. Bigger bumps mean more dollars.

Insiders with a similar print

  1. Mark ZuckerbergCEO · META · 100% match
  2. Edward Grunde McLaughlinCTO, President · MA · 100% match
  3. Satya NadellaCEO · MSFT · 100% match
  4. Jennifer K. MannPresident · KO · 99% match
  5. Jeffrey HenleyChair · ORCL · 99% match

Matched on seven traits of each insider's trading pattern (buy share, pace, typical size, planned sales, seasonality, buying after drops, number of companies). Pattern matching on public filings; history, not a prediction.

Reported trades

Filed Stock Type Shares Price Value Since
Feb 26SEC VRTXVertex Pharmaceuticals Inc / Ma Sell Plan 1,84655,570 held (−3%) $486.35 $898K +7.2%
Feb 23SEC VRTXVertex Pharmaceuticals Inc / Ma Sell Plan 920116,627 held (−1%) $463.91 $427K +12.4%
Feb 23SEC VRTXVertex Pharmaceuticals Inc / Ma Sell Plan 2,730113,897 held (−2%) $465.05 $1.3M +12.1%
Feb 23SEC VRTXVertex Pharmaceuticals Inc / Ma Sell Plan 1,848112,049 held (−2%) $465.80 $861K +11.9%
Feb 23SEC VRTXVertex Pharmaceuticals Inc / Ma Sell Plan 10,263101,786 held (−9%) $467.75 $4.8M +11.4%
Feb 23SEC VRTXVertex Pharmaceuticals Inc / Ma Sell Plan 19,66282,124 held (−19%) $468.57 $9.2M +11.3%
Feb 23SEC VRTXVertex Pharmaceuticals Inc / Ma Sell Plan 7,24174,883 held (−9%) $469.61 $3.4M +11.0%
Feb 23SEC VRTXVertex Pharmaceuticals Inc / Ma Sell Plan 11,71263,171 held (−16%) $470.54 $5.5M +10.8%
Feb 23SEC VRTXVertex Pharmaceuticals Inc / Ma Sell Plan 4,23758,934 held (−7%) $471.43 $2.0M +10.6%
  • Sell

    Evp Chief Patient & Ext Af Off Amit Sachdev sold $898K of VRTX at $486.35 — pre-scheduled 10b5-1 plan sale.

  • Sell

    Evp Chief Patient & Ext Af Off Amit Sachdev sold $427K of VRTX at $463.91 — pre-scheduled 10b5-1 plan sale.

  • Sell

    Evp Chief Patient & Ext Af Off Amit Sachdev sold $1.3M of VRTX at $465.05 — pre-scheduled 10b5-1 plan sale.

  • Sell

    Evp Chief Patient & Ext Af Off Amit Sachdev sold $861K of VRTX at $465.80 — pre-scheduled 10b5-1 plan sale.

  • Sell

    Evp Chief Patient & Ext Af Off Amit Sachdev sold $4.8M of VRTX at $467.75 — pre-scheduled 10b5-1 plan sale.

  • Sell

    Evp Chief Patient & Ext Af Off Amit Sachdev sold $9.2M of VRTX at $468.57 — pre-scheduled 10b5-1 plan sale.

Follow Amit Sachdev

Get one email when Amit Sachdev files a new purchase or sale. Free.

At most one email a day about Amit Sachdev, plus the free Monday email. Already subscribed? Use the same email to add them. Unsubscribe anytime. Facts from public filings, not advice.